| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $105.7M | +35.4% |
| Cost of Revenue | $52.2M | +34.7% |
| Gross Profit | $53.5M | +36.2% |
| R&D Expense | $14.1M | +43.6% |
| SG&A Expense | $29.2M | -13.9% |
| Operating Income | -$8.3M | +59.1% |
| Interest Expense | $809K | -50.4% |
| Pre-tax Income | -$39.6M | -217.7% |
| Income Tax | $28K |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $35.5M | +75.2% |
| Accounts Receivable | $22.9M | +89.0% |
| Inventory | $15.3M | +45.3% |
| Current Assets | $81.9M | +77.6% |
| Total Assets | $85.6M | +72.9% |
| Current Liabilities | $44.2M | +21.4% |
| Long-term Debt | $2.5M | -43.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$10.8M | +3.7% |
| Capital Expenditures | $273K | +680.0% |
| Investing Cash Flow | -$943K | -23.9% |
| Financing Cash Flow | $32.1M | +100.2% |
| Free Cash Flow | -$11.1M | +1.6% |
| -48.1% |
| Net Income | -$39.7M | -216.5% |
| EPS (Basic) | -$2.31 | -47.1% |
| Total Liabilities |
| $50.2M |
| -24.4% |
| Stockholders' Equity | $19.0M | +164.0% |